Nanoscale metal-organic frameworks for biomedical imaging and drug delivery.

Metal-organic frameworks (MOFs), a class of hybrid materials formed by the self-assembly of polydentate bridging ligands and metal-connecting points, have been studied for a variety of applications. Recently, these materials have been scaled down to nanometer sizes, and this Account details the development of nanoscale metal-organic frameworks (NMOFs) for biomedical applications. NMOFs possess several potential advantages over conventional nanomedicines such as their structural and chemical diversity, their high loading capacity, and their intrinsic biodegradability. Under relatively mild conditions, NMOFs can be obtained as either crystalline or amorphous materials. The particle composition, size, and morphology can be easily tuned to optimize the final particle properties. Researchers have employed two general strategies to deliver active agents using NMOFs: by incorporating active agents into the frameworks or by loading active agents into the pores and channels of the NMOFs. The modification of NMOF surfaces with either silica coatings or organic polymers improves NMOF stability, fine-tunes their properties, and imparts additional functionality. Preliminary biomedical applications of NMOFs have focused on their use as delivery vehicles for imaging contrast agents and molecular therapeutics. Because NMOFs can carry large amounts of paramagnetic metal ions, they have been extensively explored as magnetic resonance imaging (MRI) contrast agents. Both Gd(3+)- and Mn(2+)-containing NMOFs have shown excellent efficacy as T(1)-weighted contrast agents with large per metal- and per particle-based MR relaxivities. Fe(3+)-containing NMOFs have demonstrated excellent T(2)-weighted contrast enhancement. Upon intravenous injection of iron carboxylate NMOFs in Wistar rats, researchers observed negative signal enhancement in the liver and spleen, which dissipated over time, indicating the degradation and clearance of the NMOF. Through the incorporation of luminescent or high Z element building blocks, NMOFs have also served as viable contrast agents for optical imaging or X-ray computed tomography (CT) imaging. Incorporation of membrane impermeable dyes into NMOFs allowed for their uptake by cancer cells and for their controlled release as the framework decomposed. NMOFs have been used to deliver anticancer drugs and other chemotherapeutics. Cisplatin prodrugs were incorporated within NMOFs at exceptionally high levels, either through use of the prodrug as the building block or through attachment of the prodrug onto the framework after synthesis. These NMOFs were encapsulated within a silica shell and targeted to cancer cells. In vitro assays revealed that the targeted NMOFs possessed similar efficacy to cisplatin, while the nontargeted NMOFs were less active. Several different therapeutic molecules were loaded within porous iron-carboxylate NMOFs at unprecedented levels. The NMOF showed sustained drug release with no burst effect, and in vitro assays revealed that the nanoencapsulated drug possessed similar efficacy to the free drug. Although still at a very early stage of development, NMOFs have already shown great promise as a novel platform for nanomedicine. The compositional tunability and mild synthetic conditions used to produce NMOFs should allow for the incorporation of other imaging and therapeutic agents and their effective delivery to targeted cells in vivo.

[1]  Wenbin Lin,et al.  Phosphorescent nanoscale coordination polymers as contrast agents for optical imaging. , 2011, Angewandte Chemie.

[2]  Dan Zhao,et al.  Surface Functionalization of Porous Coordination Nanocages Via Click Chemistry and Their Application in Drug Delivery , 2011, Advanced materials.

[3]  Jens Frahm,et al.  Manganese-enhanced magnetic resonance imaging. , 2011, Methods in molecular biology.

[4]  Wenbin Lin,et al.  Nanoscale Metal—Organic Frameworks: Magnetic Resonance Imaging Contrast Agents and Beyond , 2010 .

[5]  M. Oh,et al.  Fluorescent octahedron and rounded-octahedron coordination polymer particles (CPPs) , 2010 .

[6]  Yan Liu,et al.  Engineering Homochiral Metal‐Organic Frameworks for Heterogeneous Asymmetric Catalysis and Enantioselective Separation , 2010, Advanced materials.

[7]  Wenbin Lin,et al.  A series of isoreticular chiral metal-organic frameworks as a tunable platform for asymmetric catalysis. , 2010, Nature chemistry.

[8]  G. Stathopoulos Liposomal cisplatin: a new cisplatin formulation , 2010, Anti-cancer drugs.

[9]  Brian P. Mehl,et al.  Energy transfer dynamics in metal-organic frameworks. , 2010, Journal of the American Chemical Society.

[10]  Wenbin Lin,et al.  Hybrid nanomaterials for biomedical applications. , 2010, Chemical Communications.

[11]  Wenbin Lin,et al.  Nanoscale Metal–Organic Frameworks: Magnetic Resonance Imaging Contrast Agents and Beyond , 2010 .

[12]  Seth M. Cohen,et al.  Postsynthetic diazeniumdiolate formation and NO release from MOFs , 2010 .

[13]  K. Uvdal,et al.  Nanoscale Ln(III)-carboxylate coordination polymers (Ln = Gd, Eu, Yb): temperature-controlled guest encapsulation and light harvesting. , 2010, Journal of the American Chemical Society.

[14]  Robert M Hoffman,et al.  Advances in cellular, subcellular, and nanoscale imaging in vitro and in vivo , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[15]  J. Hernando,et al.  Coordination polymer particles as potential drug delivery systems. , 2010, Chemical Communications.

[16]  Christian Serre,et al.  Biodegradable therapeutic MOFs for the delivery of bioactive molecules. , 2010, Chemical communications.

[17]  K. Kaneko,et al.  Selective inclusion of anionic quantum dots in coordination network shells of nucleotides and lanthanide ions. , 2010, Chemical communications.

[18]  Guodong Qian,et al.  Metal-organic frameworks with functional pores for recognition of small molecules. , 2010, Accounts of chemical research.

[19]  Wenbin Lin,et al.  Metal-organic frameworks as potential drug carriers. , 2010, Current opinion in chemical biology.

[20]  N. Kimizuka,et al.  Switching on luminescence in nucleotide/lanthanide coordination nanoparticles via synergistic interactions with a cofactor ligand. , 2010, Chemistry.

[21]  J. Fei,et al.  Self‐Assembly of Peptide‐Inorganic Hybrid Spheres for Adaptive Encapsulation of Guests , 2010, Advanced materials.

[22]  Gérard Férey,et al.  Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. , 2010, Nature materials.

[23]  Zhigang Xie,et al.  Porous phosphorescent coordination polymers for oxygen sensing. , 2010, Journal of the American Chemical Society.

[24]  C. Feldmann,et al.  ZrO(HPO(4))(1-x)(FMN)(x): quick and easy synthesis of a nanoscale luminescent biomarker. , 2010, Angewandte Chemie.

[25]  Shuhua Liu,et al.  Silica-coated metal nanoparticles. , 2009, Chemistry, an Asian journal.

[26]  Guohua Cao,et al.  Iodinated nanoscale coordination polymers as potential contrast agents for computed tomography. , 2009, Angewandte Chemie.

[27]  N. Kimizuka,et al.  Confining molecules within aqueous coordination nanoparticles by adaptive molecular self-assembly. , 2009, Angewandte Chemie.

[28]  Zhigang Xie,et al.  Postsynthetic modifications of iron-carboxylate nanoscale metal-organic frameworks for imaging and drug delivery. , 2009, Journal of the American Chemical Society.

[29]  H. Burt,et al.  Polymeric drug delivery of platinum-based anticancer agents. , 2009, Journal of pharmaceutical sciences.

[30]  Taeghwan Hyeon,et al.  Inorganic Nanoparticles for MRI Contrast Agents , 2009 .

[31]  Nathaniel L Rosi,et al.  Cation-triggered drug release from a porous zinc-adeninate metal-organic framework. , 2009, Journal of the American Chemical Society.

[32]  C. Sangregorio,et al.  Cyano-bridged coordination polymer nanoparticles , 2009 .

[33]  M. D. Rowe,et al.  Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[34]  Hong-Cai Zhou,et al.  Selective gas adsorption and separation in metal-organic frameworks. , 2009, Chemical Society reviews.

[35]  Omar K Farha,et al.  Metal-organic framework materials as catalysts. , 2009, Chemical Society reviews.

[36]  Alexander M. Spokoyny,et al.  Infinite coordination polymer nano- and microparticle structures. , 2009, Chemical Society reviews.

[37]  Wenbin Lin,et al.  Enantioselective catalysis with homochiral metal-organic frameworks. , 2009, Chemical Society reviews.

[38]  Laure Catala,et al.  Functional coordination nanoparticles. , 2009, Inorganic chemistry.

[39]  Shouheng Sun,et al.  Incorporation of Fe3O4 nanoparticles into organometallic coordination polymers by nanoparticle surface modification. , 2009, Angewandte Chemie.

[40]  Inhar Imaz,et al.  Metal-organic spheres as functional systems for guest encapsulation. , 2009, Angewandte Chemie.

[41]  M. D. Rowe,et al.  Polymer-modified gadolinium metal-organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer. , 2009, Biomacromolecules.

[42]  Makoto Hashizume,et al.  Nanoparticles of adaptive supramolecular networks self-assembled from nucleotides and lanthanide ions. , 2009, Journal of the American Chemical Society.

[43]  Wenbin Lin,et al.  Modular synthesis of functional nanoscale coordination polymers. , 2009, Angewandte Chemie.

[44]  K. Kaneko,et al.  Controlled self-assembly of nucleotide-lanthanide complexes: specific formation of nanofibers from dimeric guanine nucleotides. , 2008, Chemical communications.

[45]  Wenbin Lin,et al.  Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging. , 2008, Journal of the American Chemical Society.

[46]  Wenbin Lin,et al.  Surfactant-assisted synthesis of nanoscale gadolinium metal-organic frameworks for potential multimodal imaging. , 2008, Angewandte Chemie.

[47]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[48]  J. Long,et al.  Hydrogen storage in microporous metal-organic frameworks with exposed metal sites. , 2008, Angewandte Chemie.

[49]  H. Zou,et al.  Polymer/silica nanocomposites: preparation, characterization, properties, and applications. , 2008, Chemical reviews.

[50]  Wenbin Lin,et al.  Nanoscale coordination polymers for platinum-based anticancer drug delivery. , 2008, Journal of the American Chemical Society.

[51]  A. Lascialfari,et al.  Cyano-bridged coordination polymer nanoparticles with high nuclear relaxivity: toward new contrast agents for MRI. , 2008, Dalton transactions.

[52]  Leaf Huang,et al.  Pharmacokinetics and biodistribution of nanoparticles. , 2008, Molecular pharmaceutics.

[53]  W. D. de Jong,et al.  Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.

[54]  Gérard Férey,et al.  Flexible porous metal-organic frameworks for a controlled drug delivery. , 2008, Journal of the American Chemical Society.

[55]  J. Bünzli,et al.  Luminescent coordination nanoparticles , 2008 .

[56]  S. Kitagawa,et al.  Template Effects in Porous Coordination Polymers , 2008 .

[57]  Kevin Brindle,et al.  New approaches for imaging tumour responses to treatment , 2008, Nature Reviews Cancer.

[58]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[59]  Tewodros Asefa,et al.  Nanoscale metal-organic frameworks as potential multimodal contrast-enhancing agents , 2007 .

[60]  Wenbin Lin,et al.  Surface modification and functionalization of nanoscale metal-organic frameworks for controlled release and luminescence sensing. , 2007, Journal of the American Chemical Society.

[61]  Gerald A Kirk,et al.  Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. , 2007, AJR. American journal of roentgenology.

[62]  Gérard Férey,et al.  Metal-organic frameworks as efficient materials for drug delivery. , 2006, Angewandte Chemie.

[63]  Omar M Yaghi,et al.  Strategies for hydrogen storage in metal--organic frameworks. , 2005, Angewandte Chemie.

[64]  Wenbin Lin,et al.  Crystal engineering of NLO materials based on metal--organic coordination networks. , 2002, Accounts of chemical research.

[65]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications , 1999 .

[66]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[67]  A. D. Watson,et al.  Metal-Based X-ray Contrast Media. , 1999, Chemical reviews.

[68]  L. Thunus,et al.  Overview of transition metal and lanthanide complexes as diagnostic tools , 1999 .

[69]  W. Bradley,et al.  MRI: The Basics , 1997 .